213 related articles for article (PubMed ID: 31775111)
41. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
Zakharova O; Luzina O; Zakharenko A; Sokolov D; Filimonov A; Dyrkheeva N; Chepanova A; Ilina E; Ilyina A; Klabenkova K; Chelobanov B; Stetsenko D; Zafar A; Eurtivong C; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2018 Aug; 26(15):4470-4480. PubMed ID: 30076000
[TBL] [Abstract][Full Text] [Related]
42. New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.
Salomatina OV; Kornienko TE; Zakharenko AL; Komarova NI; Achara C; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338326
[TBL] [Abstract][Full Text] [Related]
43. Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes.
Gao R; Huang SY; Marchand C; Pommier Y
J Biol Chem; 2012 Aug; 287(36):30842-52. PubMed ID: 22822062
[TBL] [Abstract][Full Text] [Related]
44. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
[TBL] [Abstract][Full Text] [Related]
45. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
Nitiss KC; Malik M; He X; White SW; Nitiss JL
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
[TBL] [Abstract][Full Text] [Related]
46. Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2.
Schellenberg MJ; Appel CD; Riccio AA; Butler LR; Krahn JM; Liebermann JA; Cortés-Ledesma F; Williams RS
Nucleic Acids Res; 2020 Jun; 48(11):6310-6325. PubMed ID: 32356875
[TBL] [Abstract][Full Text] [Related]
47. Isoeugenol is a selective potentiator of camptothecin cytotoxicity in vertebrate cells lacking TDP1.
Elsayed W; El-Shafie L; Hassan MK; Farag MA; El-Khamisy SF
Sci Rep; 2016 May; 6():26626. PubMed ID: 27220325
[TBL] [Abstract][Full Text] [Related]
48. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
49. ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells.
Bian K; Muppani NR; Elkhadragy L; Wang W; Zhang C; Chen T; Jung S; Seternes OM; Long W
Oncotarget; 2016 Feb; 7(6):6665-75. PubMed ID: 26701725
[TBL] [Abstract][Full Text] [Related]
50. Post-translational regulation of Tyrosyl-DNA phosphodiesterase (TDP1 and TDP2) for the repair of the trapped topoisomerase-DNA covalent complex.
Bhattacharjee S; Rehman I; Nandy S; Das BB
DNA Repair (Amst); 2022 Mar; 111():103277. PubMed ID: 35101776
[TBL] [Abstract][Full Text] [Related]
51. RAD54L2 counters TOP2-DNA adducts to promote genome stability.
D'Alessandro G; Morales-Juarez DA; Richards SL; Nitiss KC; Serrano-Benitez A; Wang J; Thomas JC; Gupta V; Voigt A; Belotserkovskaya R; Goh CG; Bowden AR; Galanty Y; Beli P; Nitiss JL; Zagnoli-Vieira G; Jackson SP
Sci Adv; 2023 Dec; 9(49):eadl2108. PubMed ID: 38055822
[TBL] [Abstract][Full Text] [Related]
52. Biochemical assays for the discovery of TDP1 inhibitors.
Marchand C; Huang SY; Dexheimer TS; Lea WA; Mott BT; Chergui A; Naumova A; Stephen AG; Rosenthal AS; Rai G; Murai J; Gao R; Maloney DJ; Jadhav A; Jorgensen WL; Simeonov A; Pommier Y
Mol Cancer Ther; 2014 Aug; 13(8):2116-26. PubMed ID: 25024006
[TBL] [Abstract][Full Text] [Related]
53. Novel TDP2-ubiquitin interactions and their importance for the repair of topoisomerase II-mediated DNA damage.
Rao T; Gao R; Takada S; Al Abo M; Chen X; Walters KJ; Pommier Y; Aihara H
Nucleic Acids Res; 2016 Dec; 44(21):10201-10215. PubMed ID: 27543075
[TBL] [Abstract][Full Text] [Related]
54. Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.
Ponomarev KY; Suslov EV; Zakharenko AL; Zakharova OD; Rogachev AD; Korchagina DV; Zafar A; Reynisson J; Nefedov AA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Chem; 2018 Feb; 76():392-399. PubMed ID: 29248742
[TBL] [Abstract][Full Text] [Related]
55. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.
Khomenko T; Zakharenko A; Odarchenko T; Arabshahi HJ; Sannikova V; Zakharova O; Korchagina D; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2016 Nov; 24(21):5573-5581. PubMed ID: 27658793
[TBL] [Abstract][Full Text] [Related]
56. Critical roles of tyrosyl-DNA phosphodiesterases in cell tolerance to carnosol-induced DNA damage.
Feng X; Wu X; Wu Y; Zhao Z; Xiang C; Bai X; Liu X; Zhao J; Takeda S; Qing Y
Cell Biol Int; 2020 Aug; 44(8):1640-1650. PubMed ID: 32301547
[TBL] [Abstract][Full Text] [Related]
57. Mitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2
Huang SN; Dalla Rosa I; Michaels SA; Tulumello DV; Agama K; Khiati S; Jean SR; Baechler SA; Factor VM; Varma S; Murai J; Miller Jenkins LM; Kelley SO; Pommier Y
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29438979
[TBL] [Abstract][Full Text] [Related]
58. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
59. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.
Sirivolu VR; Vernekar SK; Marchand C; Naumova A; Chergui A; Renaud A; Stephen AG; Chen F; Sham YY; Pommier Y; Wang Z
J Med Chem; 2012 Oct; 55(20):8671-84. PubMed ID: 23006064
[TBL] [Abstract][Full Text] [Related]
60. Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.
Zhao H; Rybak P; Dobrucki J; Traganos F; Darzynkiewicz Z
Cytometry A; 2012 Jan; 81(1):45-51. PubMed ID: 22140093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
